Syndax Pharmaceuticals Inc. (SNDX)
NASDAQ · Healthcare
Syndax Pharmaceuticals Inc. Operating Income 2015–2025
Syndax Pharmaceuticals Inc. annual/quarterly operating income history and growth rate from 2015 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Syndax Pharmaceuticals Inc. operating income for the quarter ending March 31, 2026 was -34.2 M, a 59.17% decrease year-over-year.
- Syndax Pharmaceuticals Inc. operating income for the twelve months ending March 31, 2026 was -244.7 M, a 18.33% decrease year-over-year.
- Syndax Pharmaceuticals Inc. annual operating income for 2025 was -273.1 M, a 19.60% decrease from 2024.
- Syndax Pharmaceuticals Inc. annual operating income for 2024 was -339.7 M, a 47.71% increase from 2023.
- Syndax Pharmaceuticals Inc. annual operating income for 2023 was -230.0 M, a 51.53% increase from 2022.
- Syndax Pharmaceuticals Inc. annual operating income for 2022 was -151.8 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Syndax Pharmaceuticals Inc. Operating Income — FAQ
Syndax Pharmaceuticals Inc. (SNDX) operating income over the last 11 years — annual and quarterly figures with year-over-year growth and charts.
What is Syndax Pharmaceuticals Inc.'s operating income?
Syndax Pharmaceuticals Inc. (SNDX) reported operating income of -$273M for fiscal 2025.
Where can I see SNDX's operating income history?
The chart and table above show Syndax Pharmaceuticals Inc.'s operating income by year and by quarter, including the growth rate.